Cited by 194Neuroendocrine regulation and behaviorSexual Differentiation and DisordersHypothalamic control of reproductive hormones

Sex differences in the effects of testosterone and its metabolites on vasopressin messenger RNA levels in the bed nucleus of the stria terminalis of rats

Open access
De Vries, GJ, Wang, Z, Bullock, NA, Numan, S·1994·The Journal of Neuroscience

Abstract

Male rats have about two times as many steroid-responsive vasopressin- immunoreactive (AVP-ir) neurons in the bed nucleus of the stria terminalis (BST) as female rats. This sex difference does not depend on differences in circulating hormone levels, since it persists in males and females that are treated with similar levels of testosterone. To analyze the cellular basis of this sex difference, we compared the effects of testosterone and its metabolites on AVP mRNA expression in the BST of males and females that were gonadectomized at 3 months of age. When rats received implants of Silastic tubing filled with testosterone, males had more cells that were labeled for AVP mRNA and more labeling per cell than females. When, in a second experiment, rats received implants of either empty tubing, or tubing with dihydrotestosterone (DHT), estradiol (E), or E plus DHT, hardly any labeled cells were found in rats with empty implants. E treatment significantly stimulated AVP mRNA expression in both sexes, but significantly more so in males, which had more cells that were labeled for AVP mRNA and more labeling per cell than females. DHT treatment by itself did not stimulate AVP mRNA expression, but when given in combination with E, it significantly increased the number of cells over that of animals treated with E alone. This increase was seen in males only. However, in both sexes, it increased the labeling per cell over that of animals treated with E only, but more so in males than in females.(ABSTRACT TRUNCATED AT 250 WORDS)

AI snapshot

Written from the paper’s full text.

TL;DR

In gonadectomized adult rats given similar testosterone implants, males had more vasopressin (AVP) mRNA-labeled cells and more labeling per cell in the bed nucleus of the stria terminalis (BST) than females. Estradiol stimulated AVP mRNA in both sexes but more in males, and adding dihydrotestosterone increased labeled-cell number only in males, suggesting sex differences in estrogen and androgen responsiveness of individual AVP-producing BST cells.

Key findings

  • With similar testosterone implants, males had more BST cells labeled for AVP mRNA than females (ANOVA, F = 12.43, df = 1/11, p < 0.01) and more grains per labeled cell (ANOVA, F = 6.63, df = 1/11, p < 0.05).
  • In the metabolite experiment, overall males had more AVP mRNA-labeled cells than females (F = 16.98, df = 1/45, p < 0.0005), treatment affected labeled-cell number (F = 114.32, df = 3/45, p < 0.0001), and treatment effects differed by sex (F = 8.43, df = 3/45, p < 0.0001).
  • Estradiol (E) significantly stimulated AVP mRNA expression in both sexes, but E-treated males had significantly more labeled cells than E-treated females. DHT alone did not stimulate AVP mRNA expression; E+DHT increased labeled-cell number over E alone in males only.
  • Among E- and E+DHT-treated animals, males had more grains per labeled cell than females (F = 14.93, df = 1/23, p < 0.001), and E+DHT-treated rats had more grains per cell than E-treated rats (F = 6.46, df = 1/23, p < 0.05); the sex × treatment interaction for grains per cell did not reach significance (F = 3.82, df = 1/23, p = 0.063).

Methods

  • Adult male and female Long-Evans rats (80–90 d old) were gonadectomized and implanted with Silastic tubing. Experiment 1: 7 males and 6 females received testosterone implants. Experiment 2: rats received empty implants (7 males, 7 females), DHT (6 males, 6 females), estradiol (6 males, 8 females), or E+DHT (6 males, 7 females).
  • Animals were decapitated 4 weeks after implantation; brains were sectioned and processed for in situ hybridization for AVP mRNA in the BST, with labeled cells and grains counted under dark-field illumination by experimenters blind to specimen identity.
  • Data were analyzed by two-way ANOVA (experiment 1) or three-way ANOVA (experiment 2) with sex and treatment as between-subject variables and side of brain as a repeated measure, followed by Newman-Keuls post hoc tests for significant interactions.

Limitations

  • The paper does not state a formal limitations section.
  • Stated in the text: in the suprachiasmatic, supraoptic, and paraventricular nuclei, labeled cells and grain density could not be determined accurately; and the sex × treatment interaction for grains per labeled cell in E- versus E+DHT-treated animals failed to reach significance (p = 0.063).
  • Evident from the text: group sizes were small (6–8 animals per group), hormone levels were not measured in this study but cited from prior implant characterizations, and grain analysis was restricted to E- and E+DHT-treated groups because empty- and DHT-treated animals had virtually no labeled cells.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.14-03-01789.1994

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

1 of 26 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    Virtually all AVP-producing cells in the BST are immunoreactive for androgen and estrogen receptors.

    “since virtually all them are immunoreactive for androgen and estrogen receptors (Axelson and Van Leeuwen, 1990;Zhou et al., 1993).”
    Quote in the paperSubstantial claim1 of 2 sources checked
    • cites Axelson and Van Leeuwen, 1990 source

      The Double-staining of ER and VP-NP section (page unavailable) reports estrogen-receptor staining in parvocellular VP cells of the BST and says no VP-NP-positive cells without that staining were seen there. The paper does not report androgen-receptor immunoreactivity in those cells, so it supports only the estrogen-receptor part of the claim. (LLM, conf=0.89)

      Experimental — accuracy not yet measured
    • cites Zhou et al., 1993

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Findingown data

    None of the suprachiasmatic, supraoptic, or paraventricular nuclei showed notable differences among the different hormonal conditions.

    “None of these nuclei, however, showed any notable differences among the different hormonal conditions.”
    Quote in the paperNot a substantial claim
  • Findingown data

    DHT treatment by itself did not stimulate AVP mRNA expression in the BST of gonadectomized male or female rats.

    “DHT treatment by itself did not stimulate AVP mRNA expression”
    • Also stated in: § Discussion · plain
      “while DHT when given by itself did not influence either.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The estradiol and DHT implants produced similar circulating hormone levels in male and female rats.
  • Findingown data

    In females, treatment with E plus DHT did not increase the number of AVP mRNA-labeled cells in the BST compared to treatment with E alone.

    “However, females treated with E+DHT did not show more cells than females treated with E only.”
    • Also stated in: § Abstract · plain
      “This increase was seen in males only.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The estradiol and DHT implants produced similar circulating hormone levels in male and female rats.
  • Findingown data

    In gonadectomized adult rats treated with testosterone implants, males had more AVP mRNA-labeled cells in the BST than females.

    “After receiving similar implants of testosterone, male rats had more AVP mRNA-labeled cells in the BST (Figs. 1,2; ANOVA, F = 12.43, df = l/l 1, p < 0.01)”
    • Also stated in: § Abstract · plain
      “When rats received implants of Silastic tubing filled with testosterone, males had more cells that were labeled for AVP mRNA and more labeling per cell than females.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The testosterone implants produced similar circulating testosterone levels in male and female rats.
  • Classified as probably not a substantial claim. 6
  • May combine two claims. 7
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    No significant differences were found in labeling between the left and right side of the brain.

    “No significant differences were found in the labeling between the left and right side of the brain.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    The decision as to how many cells will express AVP depends largely on hormonal differences in the second week after birth, whereas the decision as to how dense the AVP-ir fiber plexus will be depends on hormonal differences in the first as well as second week after birth.

    “Interestingly, the latter study indicated that the decision as to how many cells will express AVP depends largely on hormonal differences in the second week after birth, whereas the decision as to how dense the AVP-ir fiber plexus will bewhich may reflect absolute number as well as AVP content of individual fibers-depends on hormonal differences in the first as well as second week after birth.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Wang et al., 1993 source
  • Classified as probably not a substantial claim.

    Study design and conductown data

    Grain counts were validated by a linear regression between pixel number and manually counted grains in 46 cells, with a correlation coefficient of r = 0.99.

    “The number of pixels was converted into number of grains using a linear regression curve that was obtained by correlating number of pixels with number of grains that were counted individually in 46 cells with grain counts ranging from 2 to 141.This gave a correlation coefficient of r = 0.99.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    The in situ hybridization and analysis of sections were done by experimenters blind to the identity of the specimens.

    “The in situ hybridization and the analysis of the sections were done by experimenters that were blind to the identity of the specimens.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductnone given

    Labeled cells were only counted if bright-field illumination revealed a Nissl-stained cell and if the number of grains was at least four times higher than background.

    “Labeled cells were identified in dark-field illuminated slides, and only counted if bright-field illumination revealed a Nissl-stained cell and if the number of grains was at least four times higher than background.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    After gonadectomy, BST cells lose AVP immunoreactivity and can no longer be labeled for AVP mRNA unless the rats are treated with testosterone.

    “After gonadectomy, BST cells lose their AVP immunoreactivity and can no longer be labeled for AVP mRNA unless the rats were treated with testosterone (De Vries et al., 1984, 1985;Van Leeuwen et al., 1985;Miller et al., 1989aMiller et al., , 1992)).”
    Quote in the paperSubstantial claim0 of 3 sources checked
    • cites De Vries et al., 1984, 1985

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites Van Leeuwen et al., 1985 source
    • cites Miller et al., 1989a

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Light intensity and camera setting were kept constant across sections to standardize measurements.

    “The light intensity and camera setting were kept constant across the sections in order to standardize measurements.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    There are sex differences in the substance P and cholecystokinin innervation of the BST, both of which are responsive to testosterone and E.

    “There are, for example, sex differences in the substance P and cholecystokinin innervation of the BST, both of which are responsive to testosterone and E (Malsbury and McKay, 1987;Simerly and Swanson, 1987;Micevych et al., 1988;Oro et al., 1988).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Malsbury and McKay, 1987 source
    • cites Simerly and Swanson, 1987

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

    • cites Micevych et al., 1988 source
  • May combine two claims.

    Interpretationown data

    The data suggest that in addition to a sex difference in the number of cells that produce AVP, there is also a sex difference in estrogen as well as androgen responsiveness in individual AVP-producing cells in the BST.

    “These data suggest that in addition to a sex difference in the number of cells that produce AVP there is also a sex difference in estrogen as well as androgen responsiveness in individual AVP-producing cells in the BST.”
    • Also stated in: § Discussion · plain
      “Furthermore, they show that there are sex differences in the responsiveness of individual BST cells to testosterone metabolites, in particular to DHT, which if given in combination with E increased the number of AVP mRNA-labeled cells in males but not in females.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The estradiol and DHT implants produced similar circulating hormone levels in male and female rats.
  • May combine two claims.

    Premisecitation

    Male rats have higher levels of aromatase and higher numbers of androgen receptors in the BST than female rats.

    “Since male rats have higher levels ofaromatase, the enzyme that catalyzes the aromatization of testosterone into E, as well as higher numbers of androgen receptors in the BST than female rats (Roselli,199 l)”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Roselli,199 1

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • May combine two claims.

    Interpretationown data

    Sexual differentiation of AVP projections of the BST entails developmental decisions about how many BST cells express AVP and the efficacy of mechanisms mediating gonadal hormone effects on AVP gene expression in individual cells.

    “The sex differences found in the present study suggest that sexual differentiation of AVP projections of the BST entails a number of developmental decisions, among which a decision as to how many BST cells will express AVP and a decision on the efficacy of the mechanisms that mediate gonadal hormone effects on AVP gene expression in individual cells.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    A recent study suggests that the developmental decisions underlying sexual differentiation of AVP projections depend on differences in the levels of gonadal hormones in the first weeks after birth.

    “A recent study suggests that these decisions depend on differences in the levels of gonadal hormones in the first weeks after birth (Wang et al., 1993).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Wang et al., 1993 source
12 of 12
  • The paper relies on this without support.

    The testosterone implants produced similar circulating testosterone levels in male and female rats.

    “implanted with Silastic tubing (2.5 cm long, 1.5 mm id., 2.4 mm o.d.) filled with testosterone, which previously yielded plasma testosterone levels of 2.4-3.6 &ml, which is in the physiological range for males (De Vries et al., 1984).”
  • The paper relies on this without support.

    The estradiol and DHT implants produced similar circulating hormone levels in male and female rats.

    “The dimensions of the Silastic tubing for E (1 cm long, 1 mm i.d., 2 mm o.d.) previously yielded plasma levels of 50-90 ne/ml E. which comnletelv suuuressed LH release in males, while the dim&sions used for DHT (3 cm, 1.5 mm and 2.4 mm o.d.) previously yielded plasma levels of 0.9-l .8rig/ml DHT, which fully restored the size of the seminal vesicles in castrated rats (De Vries et al., 1986).”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • This sex difference in AVP expression is organized during early postnatal life by steroid hormone actions on ER and AR.

    “Moreover, this sex difference is organized during early postnatal life by steroid hormone actions on ER and AR.[24][25][26]”

    From Neonatal MeCP2 is important for the organization of sex differences in vasopressin expression (2012) · cites this paper as [25]

    The Discussion reports that differences in gonadal hormones during the first weeks after birth help determine the sexual differentiation of AVP-producing cells in the rat BST. The paper also discusses estrogen- and androgen-receptor mechanisms affecting AVP expression, but it does not establish that actions on both receptors during early postnatal life organize the sex difference; those receptor mechanisms are discussed in the context of hormone responsiveness and remain partly hypothetical. Page numbers are unavailable in our copy. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
De Vries, G., Wang, Z., Bullock, N., & Numan, S.
Affiliations
University of Massachusetts Amherst (US)
Venue
The Journal of Neuroscience
Published
1994-03-01
Volume
14
Issue
3
Pages
1789-1794
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2101036608
Cited by
193
References
35
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 10 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 6 · 2017: 7 · 2016: 2 · 2015: 4 · 2014: 6 · 2013: 8 · 2012: 9
FWCI
10.94
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • Digital Archive @ GSU (submittedVersion, cc-by-nc-sa)
  • Counseling And Psychological Services Dissertations (Georgia State University) (submittedVersion, cc-by-nc-sa)
  • ScholarWorks@UMassAmherst (University of Massachusetts Amherst) (submittedVersion)
Funders
National Institute of Mental Health (NIMH RO1 MH47538)
Topics
  • Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
sex differences, testosterone, dihydrotestosterone, estradiol, vasopressin, bed nucleus of the stria terminalis, gonadectomy, rats
MeSH terms
Animals, Arginine Vasopressin, Castration, Drug Combinations, Estradiol, Female, Male, Rats, Inbred Strains, RNA, Messenger, Sex Characteristics, Dihydrotestosterone, Testosterone, Thalamus, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-12.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-12.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review